| Literature DB >> 7887020 |
E A DeVelasco1, H A Dekker, P Antal, K P Jalink, J A van Strijp, A F Verheul, J Verhoef, H Snippe.
Abstract
The adjuvant effect of Quil A on the primary antibody response of mice to pneumococcal capsular polysaccharide conjugates was examined. Quil A increased the anti-capsular polysaccharide antibody titres, the protection against Streptococcus pneumoniae, and the opsonic capacity of the antibodies as measured in a newly developed in vitro phagocytosis assay, using the mouse macrophage cell line J774.Entities:
Mesh：
Substances：
Year: 1994 PMID： 7887020 DOI： 10.1016/0264-410x(94)90151-1
Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641